<DOC>
	<DOCNO>NCT02544139</DOCNO>
	<brief_summary>This study assess specificity Chagas Detect™ Plus ( CDP ) rapid test versus standard reference test ( e.g . RIPA IFA ) Chagas diagnosis US . The Chagas Detect™ Plus Rapid Test rapid immunochromotagraphic strip assay qualitative detection antibody Trypanosoma cruzi ( T. cruzi ) human serum whole blood sample . Reactive assay result presumptive evidence Chagas infection . This study enroll male females 18-70 year age area non-endemic Chagas infection . A fingerprick blood sample venous blood sample ( process serum ) collect subject . Subject age , gender , symptom record . For study , sample personally identifiable information . CDP reference test perform different operator laboratory staff member . These staff member , blind 's result , evaluate sample method independently .</brief_summary>
	<brief_title>Specificity Study Diagnostic Chagas Disease</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<criteria>1 . Male female subject 18 70 year age 2 . Subjects must able answer question concern : 1 . Clinical symptom 2 . Blood transfusion 3 . Organ transplant 4 . Travel residence Chagas endemic area 1 . Any subject know positive serology Chagas disease 2 . Subjects unable understand verbal write oral language consent , require legal authorize representative consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>